CBD Industry Group Commits To Compliance With EU Novel Food Law
Seeking to end the current impasse between regulators and the CBD industry, the Centre For Medicinal Cannabis is launching a quality charter for its members to put their products “on the path to regulatory compliance.”
You may also be interested in...
Major retailers LloydsPharmacy and Holland & Barrett remain unfazed by the regulatory chaos surrounding cannabidiol (CBD) in the UK, while pharmacy groups become increasingly concerned that their members may be selling controlled substances due to the possible presence of tetrahydrocannabinol (THC).
UK's Royal Pharmaceutical Society calls on government to clarify permissible THC levels in CBD oils to avoid pharmacists selling illegal products.
Cannabis trade association CannaPro is threatening legal action against the UK's Food Standards Agency for its response to moves by EU regulators to classify CBD as a novel Food. The FSA's handling of the situation is negatively impacting business, states CannaPro, which has warned the agency it will sue for damages.